The Effect of Hospital and Surgeon Volume on Racial Differences in Recurrence-Free Survival After Radical Prostatectomy

被引:34
|
作者
Gooden, Kyna M. [1 ]
Howard, Daniel L. [1 ]
Carpenter, William R. [2 ,3 ]
Carson, April P. [1 ]
Taylor, Yhenneko J. [1 ]
Peacock, Sharon [4 ]
Godley, Paid A. [2 ,5 ]
机构
[1] Shaw Univ, Inst Hlth Social & Community Res, Raleigh, NC 27601 USA
[2] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
[3] Univ N Carolina, Sch Publ Hlth, Dept Hlth Policy & Adm, Chapel Hill, NC 27599 USA
[4] Carolinas Ctr Med Excellence, Cary, NC USA
[5] Univ N Carolina, Div Hematol Oncol, Chapel Hill, NC USA
基金
美国国家卫生研究院;
关键词
prostate cancer; survival; hospital volume; surgeon volume; racial disparities;
D O I
10.1097/MLR.0b013e31817d696d
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective: This Study investigates associations between hospital and surgeon volume, and racial differences in recurrence after surgery for prostate cancer. Methods: Data from the 1991 to 2002 Surveillance, Epidemiology, and End- Results-Medicare database were examined for 962 black and 7387) white men who received Surgery for prostate cancer within 6 months of diagnosis during 1993-1999. Cox regression models used to estimate the relationships between volume (grouped in tertiles), recurrence or death, and race. controlling for age. Gleason grade, and comorbidity score. Results: prostate cancer recurrence-free Survival rates improved with hospital and Surgical Volume. Black men were more likely to experience recurrence than white men [hazard ratio (FIR) = 1.34 959/0 confidence interval (Cl): 1.20-1.50]. Stratification by hospital Volume revealed that racial differences persisted for medium and high volume hospitals, even after covariate adjustments (medium HR = 1.30, 95% CI: 1.04-1.61; high HR = 1.36. 9-5% CI: 1.07-1.73). Racial differences persisted Within medium and high levels of Surgeon volume as well (medium HR = 1.43, 95% CI: 1.10-1.85: high HR = 1.57. 95%, CI: 1.14-2.16). Conclusions: High hospital and physician volumes were not associated with reduced racial differences in recurrence-free Survival after prostate cancer Surgery, contrary to expectation. This Study suggests that social and behavioral characteristics, and some aspects of access, may play a larger role than organizational or systemic characteristics with regard to recurrence-free survival for this population.
引用
收藏
页码:1170 / 1176
页数:7
相关论文
共 50 条
  • [41] Biochemical Recurrence After Radical Prostatectomy: is the Disease or the Surgeon to Blame?
    Simsir, Adnan
    Cal, Cag
    Mammadov, Rashad
    Curekhbatir, Ibrahim
    Semerei, Bulent
    Gunaydin, Gurhan
    INTERNATIONAL BRAZ J UROL, 2011, 37 (03): : 328 - 334
  • [43] RACIAL DISPARITIES IN RECURRENCE-FREE CERVICAL CANCER SURVIVAL IN KENTUCKY.
    Das, N.
    Groves, F. D.
    Gupta, R. C.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2009, 169 : S51 - S51
  • [44] PITX3 promoter methylation is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients after radical prostatectomy
    Emily Eva Holmes
    Diane Goltz
    Verena Sailer
    Maria Jung
    Sebastian Meller
    Barbara Uhl
    Jörn Dietrich
    Magda Röhler
    Jörg Ellinger
    Glen Kristiansen
    Dimo Dietrich
    Clinical Epigenetics, 2016, 8
  • [45] Aberrant Methylation of PCDH10 Predicts Worse Biochemical Recurrence-Free Survival in Patients with Prostate Cancer After Radical Prostatectomy
    Wang, Li
    Xie, Pei-Gen
    Lin, Ying-Li
    Ma, Jian-Guo
    Li, Wen-Ping
    MEDICAL SCIENCE MONITOR, 2014, 20
  • [46] Conditional biochemical recurrence-free survival and cancer-specific mortality after radical prostatectomy at long term follow-up.
    Barreras, Silvia Garcia
    Sanchez-Salas, Rafael
    Nunes-Silva, Igor
    Secin, Fernando P.
    Srougi, Victor
    Baghdadi, Mohammed
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [47] A Novel Gene Signature-Based Model Predicts Biochemical Recurrence-Free Survival in Prostate Cancer Patients after Radical Prostatectomy
    Shi, Run
    Bao, Xuanwen
    Weischenfeldt, Joachim
    Schaefer, Christian
    Rogowski, Paul
    Schmidt-Hegemann, Nina-Sophie
    Unger, Kristian
    Lauber, Kirsten
    Wang, Xuanbin
    Buchner, Alexander
    Stief, Christian
    Schlomm, Thorsten
    Belka, Claus
    Li, Minglun
    CANCERS, 2020, 12 (01)
  • [48] PITX3 promoter methylation is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients after radical prostatectomy
    Holmes, Emily Eva
    Goltz, Diane
    Sailer, Verena
    Jung, Maria
    Meller, Sebastian
    Uhl, Barbara
    Dietrich, Joern
    Roehler, Magda
    Ellinger, Joerg
    Kristiansen, Glen
    Dietrich, Dimo
    CLINICAL EPIGENETICS, 2016, 8
  • [49] Role of surgeon and surgeon volume in erectile function recovery after radical prostatectomy
    Bianco, FJ
    Kattan, MW
    Eastham, JA
    Guillonneau, B
    Scardino, PT
    Mulhall, JP
    JOURNAL OF UROLOGY, 2006, 175 (04): : 70 - 70
  • [50] Anatomic radical retropubic prostatectomy-long-term recurrence-free survival rates for localized prostate cancer
    Chun, Felix K. -H.
    Graefen, Markus
    Zacharias, Mario
    Haese, Alexander
    Steuber, Thomas
    Schlomm, Thorsten
    Karakiewicz, Pierre I.
    Huland, Hartwig
    WORLD JOURNAL OF UROLOGY, 2006, 24 (03) : 273 - 280